Irbesartan
厄贝沙坦
Report date: 2026/05/26 20:00:28
NME
Base Information
Drug NameIrbesartan
Drug Alias Name +[13]
Classification
Mechanisms of Action
Targets
Therapy Area/Indications +[16]
Global Approved Indications
Approved Indications in China
Original Approved Country/Territory
Original Approved Date1997/08/26
Country/Territory +[35]
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesSanofi
China Registration ClassN/A
Develop Information
Active CompaniesSumitomo DainipponSanofiBracco Diagnostics Inc +[6]
Inactive CompaniesAugusta UniversityBristol Myers Squibb SrlcompanyUniversity Of Salerno +[9]
Active Indications
Inactive Indications +[13]